Source: Annual Congress 2004 - Clinical application of lung function in early life
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
W. Hofhuis, E. C. van der Wiel, E. M. Nieuwhof, J. C. De Jongste, M. J. Affourtit, F. J. Smit, A. A. Vaessen-Verberne, F. G. Versteegh, P. J. Merkus, AIR Study Group (Rotterdam, Breda, Gouda, The Netherlands). Efficacy of fluticasone propionate on lung function and symptoms in wheezy infants. Eur Respir J 2004; 24: Suppl. 48, 2910

Member's Comments

No comment yet.

Related content which might interest you: Efficacy of fluticasone propionate in infants younger than two years with asthma Source: Eur Respir J 2005; 26: Suppl. 49, 159s Year: 2005 Montelukast compared with fluticasone proprionate in children with persistent asthma Source: ISSN=ISSN 1810-6838, ISBN=, page=267 Year: 2006 Efficacy and safety of ciclesonide compared with fluticasone propionate or budesonide in adolescent patients with persistent asthma Source: Eur Respir J 2007; 30: Suppl. 51, 458s Year: 2007 Effects of fluticasone propionate in young children with recurrent wheeze after RSV bronchiolitis Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome Year: 2007 Ciclesonide and fluticasone propionate show comparable efficacy in children and adolescents with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 346s Year: 2004 The effects of fluticasone propionate in asthmatic patients Source: Eur Respir J 2004; 24: Suppl. 48, 125s Year: 2004 Efficacy and safety of ciclesonide compared with fluticasone propionate in patients with moderate to severe asthma Source: Eur Respir J 2006; 28: Suppl. 50, 206s Year: 2006 Effect of discontinuation of inhaled fluticasone propionate on exacerbations in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 183s Year: 2001 Aerosolized fluticasone propionate therapy in acute moderate exacerbations of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 45s Year: 2002 Efficacy of high-dose inhaled fluticasone propionate in Indian patients having moderate asthma Source: Eur Respir J 2002; 20: Suppl. 38, 305s Year: 2002 Response to fluticasone propionate in controlling airway inflammation in steroid-naïve asthma patients Source: Eur Respir J 2006; 28: Suppl. 50, 317s Year: 2006 Safety profile of ciclesonide as compared with fluticasone propionate in the treatment of children and adolescents with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 346s Year: 2004 Clinical disposition, safety and efficacy of fluticasone propionate (FP) in pre-school children with persistent wheeze and asthma-like symptoms Source: Eur Respir J 2002; 20: Suppl. 38, 219s Year: 2002 Effect of fluticasone and montelukast in preschool children with asthma-like symptoms Source: Eur Respir J 2006; 28: Suppl. 50, 709s Year: 2006 Effect of inhaled corticosteroid fluticasone propionate on linear growth in preschool children with asthma Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma Year: 2007 Comparison of fluticasone propionate and budesonide on phagocytosis of common respiratory pathogens in COPD patients Source: Annual Congress 2011 - Immunology and cell biology of asthma and COPD Year: 2011 Treatment effectiveness and exacerbations during one year with seretide compared to fluticasone propionate and salmeterol in mild-to-moderate asthma Source: Eur Respir J 2001; 18: Suppl. 33, 176s Year: 2001 Adrenal suppression from high-dose inhaled fluticasone propionate in children with asthma Source: Eur Respir J 2004; 23: 354-355 Year: 2004 Does fluticasone propionate (FP) improve pulmonary function in asthmatic infants? Source: Eur Respir J 2003; 22: Suppl. 45, 495s Year: 2003 Efficacy of salmeterol/fluticasone propionate MDI versus higher dose fluticasone propionate in adolescent and adult asthmatics uncontrolled on fluticasone propionate alone Source: Eur Respir J 2003; 22: Suppl. 45, 438s Year: 2003